APA (7th ed.) Citation

O, J., N, O., GK, D., S, S., D, B., AG, J., . . . K, M. (2026). Inhibition of PfCLK3 interferes with malaria parasite RNA splicing and explains the mechanism of action of a new class of antimalarial candidates. Antimicrobial agents and chemotherapy, e0156125. https://doi.org/10.1128/aac.01561-25

Chicago Style (17th ed.) Citation

O, Janha, Olaniyan N, Diam GK, Sharma S, Beraldi D, Jamieson AG, Bozdech Z, Tobin AB, and Modrzynska K. "Inhibition of PfCLK3 Interferes with Malaria Parasite RNA Splicing and Explains the Mechanism of Action of a New Class of Antimalarial Candidates." Antimicrobial Agents and Chemotherapy 2026: e0156125. https://doi.org/10.1128/aac.01561-25.

MLA (9th ed.) Citation

O, Janha, et al. "Inhibition of PfCLK3 Interferes with Malaria Parasite RNA Splicing and Explains the Mechanism of Action of a New Class of Antimalarial Candidates." Antimicrobial Agents and Chemotherapy, 2026, p. e0156125, https://doi.org/10.1128/aac.01561-25.